The Skin Cancer Foundation Journal

MAY 2013

The 2012 edition of The Skin Cancer Foundation Journal features medically reviewed, reader-friendly articles such as tanning, the increasing incidence of skin cancer diagnoses among young women, & the prevalence of melanoma among white males over 50.

Issue link: https://skincancer.epubxp.com/i/131479

Contents of this Issue

Navigation

Page 95 of 103

8 American Cancer Society. Cancer Facts and Figures 2011. http:// www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-029771.pdf A HAiRCut CouLD sAVe YouR LiFe (p .44) 1 Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol 2008; 144(4):515-521. 2 Hareyan A. Scalp, neck melanomas most dangerous: carcinoid symptoms. EmaxHealth. http://www.emaxhealth.com/101/21814. html. April 22, 2008. Accessed Dec. 10, 2012. 3 Frangou C. Scalp melanomas carry worse survival prognosis than other melanomas. General Surgery News 2012; 39(08). Accessed Dec. 10, 2012. 4 Bailey EE, Marghoob AA, Orengo IF, et al. Skin cancer knowledge, attitudes, and behaviors in the salon: a survey of working hair professionals in Houston, Texas. Arch Dermatol 2011; 147(10):1159-1165. 5 American Cancer Society. Cancer Facts & Figures 2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf. Accessed Jan. 22, 2013. skin CAnCeR pReVention stRAtegies: tRieD, tRue, & new (p .51) 1 Rogers, HW, Weinstock, MA, Harris, AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146(3):283-287. 2 American Cancer Society. Cancer Facts & Figures 2012. http:// www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-031941.pdf. 3 The Lewen Group, Inc. The burden of skin diseases 2005. The Society for Investigative Dermatology and the American Academy of Dermatology Association. 2005. 4 Moy RL, Taheri DP, Ostad A. Practical Management of Skin Cancer. 1st ed. Philadelphia, PA: Lippincott-Raven Publications, 1999. 5 Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329(16):1147-51. 6 Diffey BL. When should sunscreen be reapplied? J Am Acad Dermatol 2001; 45(6):882-885. 7 Teramura T, Mizuno M, Asano H, et al. Relationship between sun-protection factor and application thickness in high-performance sunscreen: double application of sunscreen is recommended. Clin Exp Dermatol 2012 Oct 10. [Epub ahead of print] 8 Moyal DD, Fourtanier AM. Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings. J Am Acad Dermatol 2008; 58(5 Suppl 2):S149-54. 9 Black HS, Herd JA, Goldberg HH, et al. Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med 1994; 330(18):1272-5. 10 Black HS. Infuence of dietary factors on actinically-induced skin cancer. Mutat Res 1998; 422(1):185-90. 11 Middelkamp-Hup MA, Pathak MA, Parrado C, et al. Oral polypodium leucotomos extract decreases ultraviolet-induced damage of human skin. J Am Acad Dermatol 2004; 51(6):910-8. 12 Stege H. Effect of xenogenic repair enzymes on photoimmunology and photocarcinogenesis. J Photochem Photobiol B 2001; 65(2-3):105-8. 13 Russo GG. Actinic keratoses, basal cell carcinoma, and squamous cell carcinoma: uncommon treatments. Clin Dermatol 2005; 23(6):581-6. 14 Kraemer KH, DiGiocanna JJ, Peck GL. Chemoprevention of skin cancer in xeroderma pigmentosum. J Dermatol 1992; 19(11):715-8. 15 Bouwes Bavinck JN, Tieben LM, Van der Woude FJ, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995; 13(8):1933-8. 16 Harwood CA, Leedham-Green M, Leigh IM, Proby CM. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas 94 in organ transplant recipients: a 16-year retrospective study. Arch Dermatol 2005; 141(4):456-64. 17 Bollag W, Ott F. Retinoic acid: topical treatment of senile or actinic keratoses and basal cell carcinomas. Agents Actions 1970; 1(4):172-5. 18 Peck GL. Hypertrophic scar after cryotherapy and topical tretinoin. Arch Dermatol 1973; 108(6):819-22. 19 Belisario JC. Recent advances in topical cytotoxic therapy of skin cancer and precancer. In: Melanoma and Skin Cancer. Sydney, Australia: Proceedings of the International Cancer Conference. Sydney; 1972:349-375. 20 Bollag W, Ott F. Vitamin A acid in benign and malignant epithelial tumours of the skin. Acta Derm Venereol Suppl. Stockholm: 1975; 74:163-6. 21 Ostertag JU, Quaedvlieg PJ, van der Geer S, et al. A clinical comparison and long-term follow-up of topical 5-fuorouracil versus laser resurfacing in the treatment of widespread actinic keratoses. Lasers Surg Med 2006; 38(8):731-9. 22 Brodland DG, Roenigk RK. Trichloroacetic acid chemexfoliation (chemical peel) for extensive premalignant actinic damage of the face and scalp. Mayo Clin Proc 1988; 63(9):887-96. 23 Rhavar M, Lamel SA, Maibach HI. Randomized, vehiclecontrolled trials of topical 5-fuorouracil therapy for actinic keratosis treatment: an overview. Immunotherapy 2012; 4(9):939-45. 24 Strohal R, Kerl H, Shuster L. Treatment of actinic keratoses with 5% topical imiquimod: a multicenter prospective observational study from 93 Austrian offce-based dermatologists. J Drugs Dermatol 2012; 11(5):574-8. 25 Weiss ET, Brauer JA, Anolik R, et al. 1927-nm fractional resurfacing of facial actinic keratoses: a promising new therapeutic option. J Am Acad Dermatol 2012 Oct 2. [Epub ahead of print.] 26 Togsverd-Bo K, Haak CS, Thaysen-Petersen D, et al. Intensifed photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol 2012; 166(6):1262-9. 27 Ostertag JU, Quaedvlieg PJ, Neumann MH, et al. Recurrence rates and long-term follow-up after laser resurfacing as a treatment for widespread actinic keratoses on the face and scalp. Dermatol Surg 2006; 32(2):261-7. ARe You wAiting FoR tHAt spot to DisAppeAR? (p .54) 1 American Cancer Society. Cancer Facts & Figures 2012. http:// www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-031941.pdf. 2 McGuire ST, Secrest AM, Andrulonis R, Ferris LK. Surveillance of patients for early detection of melanoma: patterns in dermatologist vs patient discovery. Arch Dermatol 2011; 147(6):673-8. doi: 10.1001/ archdermatol.2011.135. 3 Alam M, Goldberg LH, Silapunt S, et al. Delayed treatment and continued growth of nonmelanoma skin cancer. J Am Acad Dermatol 2011; 64(5):839-48. Cut to tHe CHAse (p .57) 1 Donaldson MR, Coldiron BM. No end in sight: the skin cancer epidemic continues. Semin Cutan Med Surg 2011; 30(1):3-5. 2 Mistry N, Abanto Z, Bajdik C, Rivers JK. Demographic and tumor characteristics of patients diagnosed with nonmelanoma skin cancer: 13-year retrospective study. J Cutan Med Surg 2012; 16(1):32-8. 3 Trost LB, Bailin PL. History of Mohs surgery. Dermatol Clin 2011; 29(2):135-9. 4 Coldiron BM, Rogers HW. A relative value unit-based cost comparison of treatment modalities for non-melanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol 2009; 61(1):96-103. 5 Ad Hoc Task Force, Connolly SM, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS. 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol 2012; 67(4):531-550. tHe ABCDs AnD BeYonD (p .61) 1 Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin 1985; 35:130-51. 2 American Cancer Society. Cancer Facts & Figures 2013. http:// www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-036845.pdf. Accessed January 31, 2013. 3 Healsmith MF, Bourke JF, Osborne JE, Graham-Brown RA. An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma. Br J Dermatol 1994; 130(1):48-50. 4 Kelly JW. Nodular melanoma: how current approaches to early detection are failing. J Drugs Dermatol 2005; 4:790-3. 5 Thomas L, Tranchand P, Berard F, et al. Semiological value of ABCDE criteria in the diagnosis of cutaneous pigmented tumors. Dermatology 1998; 197:11-7. 6 Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 2004; 292:2771-6. 7 Yagerman S, Chen L, Jaimes N, Dusza S, Halpern A, Marghoob A. Hunting for the ugly DUC-ling: the importance of Differential recognition, Unevenness in distribution of colors and texture, and history of Change for early melanoma recognition. HemOnc Today Melanoma and Cutaneous Malignancies Meeting 2013. Poster presentation. 8 Shaw HM, McCarthy WH. Small-diameter malignant melanoma: a common diagnosis in New South Wales, Australia. J Am Acad Dermatol 1992; 27(5 Pt 1):679-82. 9 Jaimes N, Braun RP, Thomas L, Marghoob AA. Clinical and dermoscopic characteristics of amelanotic melanomas that are not of the nodular subtype. J Eur Acad of Dermatol Venereol 2012; 26(5):591-6. 10 Girardi S, Gaudy C, Gouvernet J, et al. Superiority of a cognitive education with photographs over ABCD criteria in the education of the general population to the early detection of melanoma: a randomized study. Int J Cancer 2006; 118(9):2276-80. 11 Marghoob AA, Scope A. The complexity of diagnosing melanoma. J Invest Dermatol 2009; 129(1):11-3. 12 Aldridge RB, Zanotto M, Ballerini L, et al. Novice identifcation of melanoma: not quite as straightforward as the ABCDs. Acta Derm Venereol 2011; 91(2):125-30. 13 Gachon J, Beaulieu P, Sei JF, et al. First prospective study of the recognition process of melanoma in dermatological practice. Arch Dermatol 2005; 141(4):434-8. 14 Scope A, Dusza SW, Halpern AC, et al. The "ugly duckling" sign: agreement between observers. Arch Dermatol 2008; 144(1):58-64. 15 Argenziano G, Longo C, Cameron A, et al. Blue-black rule: a simple dermoscopic clue to recognize pigmented nodular melanoma. Br J Dermatol 2011; 165(6):1251-5. 16 Marghoob AA, Korzenko AJ, Changchien L, et al. The beauty and the beast sign in dermoscopy. Dermatol Surg 2007; 33(11):1388-1391. LiMiting inDooR tAnning: A woRLDwiDe initiAtiVe to sAVe LiVes (p .65) 1 Rogers, HW, Weinstock, MA, Harris, AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146(3):283-287. 2 Levine JA, Sorace M, Spencer J, Siegel DM. The indoor UV tanning industry: a review of skin cancer risk, health beneft claims, and regulation. J Am Acad Dermatol 2005; 53(6):1038-44. 3 Kwon HT, Mayer JA, Walker KK, et al. Promotion of frequent tanning sessions by indoor tanning facilities: two studies. J Am Acad Dermatol 2003; 46:700-5. 4 Bataille V, Boniol M, De Vries E, et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer 2005; 41(14):2141-9. 5 International Agency for Research on Cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 2007; 120(5):1116-22. SK I N C A NCER FOU N DAT ION JOU R NA L

Articles in this issue

Links on this page

Archives of this issue

view archives of The Skin Cancer Foundation Journal - MAY 2013